news

Our latest
Press Releases & Updates

Latest press releases

RetinAI and Retina Consultants of America Join Forces to build the Most Comprehensive U.S.-based Real World Evidence Database in Ophthalmology

RetinAI Medical AG and Retina Consultants of America (RCA) forge a strategic partnership to revolutionize Ophthalmology data. Leveraging RetinAI's advanced AI technologies and RCA's expansive clinic network, this alliance is set to develop the largest Real World Evidence (RWE) U.S.-based database in the field.

RetinAI Joins Forces with Boehringer Ingelheim to Advance Novel Treatments for Patients with Geographic Atrophy using Artificial Intelligence

RetinAI Medical AG has announced a partnership with Boehringer Ingelheim to improve patient outcomes in geographic atrophy (GA). RetinAI's AI tools for identifying novel biomarkers will be used to analyze Boehringer Ingelheim's imaging datasets from clinical studies and real-world evidence to identify additional biomarkers and predictors of disease progression. This partnership aims to accelerate the development of novel treatments and enable earlier and more precise diagnosis, contributing to Boehringer Ingelheim's vision of preventing vision loss and blindness caused by retinal diseases.

RetinAI’s AI Algorithms Enrich Clinical Research and Improve Patient Care

RetinAI Medical AG has announced the acceptance of five abstracts for poster presentations at the Association for Research in Vision and Ophthalmology (ARVO) conference taking place from April 23rd to 26th, 2023 in New Orleans. These studies highlight the potential of RetinAI’s Discovery platform and its certified and research use only (RUO) AI models to revolutionize healthcare decisions, improve patient care, help accelerate clinical trials, and drive better decisions for patient management.

RetinAI and Geographic Atrophy (GA) Expert Working Group partner to enable data collaboration and automated analysis of GA biomarkers for CAM using Discovery

RetinAI partnered with the Classification of Atrophy Meeting (CAM) Group in December 2022 to provide RetinAI’s Discovery® platform to the expert working group, consisting of more than 30 members, to facilitate peer-to-peer data collaboration and perform accelerated, automated biomarker analysis of real-world datasets of geographic atrophy (GA) patients.

NVIDIA GTC Europe 2018 [OCTOBER’18]

RetinAI was one of the 10 startup to present on the NVIDIA GTC Europe Inception Awards 2018. Hundreds of applications, 70 teams in the pitching semi-finals and only 10 teams in the final. What a great opportunity to show the world how Artificial Intelligence is going to change the standard of eye care in 2019.

‍

Venture Leaders China 2018 [SEPTEMBER'18]

The 10-day business roadshow in China with VentureLab is only a week away! Get to know the Venture Leaders China team member Carlos Ciller, CEO & co-founder of RetinAI before the trip begins! Source: VentureLab.

Welcome to the new RetinAI [SEPTEMBER'18]

There's nothing permanent except change - Heraclitus. We are incredibly pleased to announce our new logo at RetinAI! This new image reflects our values, strengths and willingness to connect the anatomical and digital worlds to provide a better healthcare for the patient.

RetinAI on the Top100 Swiss Startups [SEPTEMBER’18]

This year RetinAI has been selected as one of the TOP 100 of Swiss Startups 2018! It’s a great recognition for the team. We are proud of the results we are achieving and we are extremely excited about the future ahead!

Our latest
Press Releases & Updates

Latest press releases

RetinAI and Retina Consultants of America Join Forces to build the Most Comprehensive U.S.-based Real World Evidence Database in Ophthalmology

RetinAI Joins Forces with Boehringer Ingelheim to Advance Novel Treatments for Patients with Geographic Atrophy using Artificial Intelligence

RetinAI’s AI Algorithms Enrich Clinical Research and Improve Patient Care

RetinAI and Geographic Atrophy (GA) Expert Working Group partner to enable data collaboration and automated analysis of GA biomarkers for CAM using Discovery

Latest updates

NVIDIA GTC Europe 2018 [OCTOBER’18]

Venture Leaders China 2018 [SEPTEMBER'18]

Welcome to the new RetinAI [SEPTEMBER'18]

RetinAI on the Top100 Swiss Startups [SEPTEMBER’18]

Contact us for more informations! We are happy to hear from you!

Sign Up And Receive Our Latest Promotions!

Our latest Press Releases & Updates

Latest press releases

RetinAI and Retina Consultants of America Join Forces to build the Most Comprehensive U.S.-based Real World Evidence Database in Ophthalmology

RetinAI Joins Forces with Boehringer Ingelheim to Advance Novel Treatments for Patients with Geographic Atrophy using Artificial Intelligence

RetinAI’s AI Algorithms Enrich Clinical Research and Improve Patient Care

RetinAI and Geographic Atrophy (GA) Expert Working Group partner to enable data collaboration and automated analysis of GA biomarkers for CAM using Discovery

Latest updates

NVIDIA GTC Europe 2018 [OCTOBER’18]

Venture Leaders China 2018 [SEPTEMBER'18]

Welcome to the new RetinAI [SEPTEMBER'18]

RetinAI on the Top100 Swiss Startups [SEPTEMBER’18]

Contact us for more informations! We are happy to hear from you!

Our latest
Press Releases & Updates